TrialStat Demonstrates New Enhancements to Clinical Analytics 3.0 at Drug Information Association Annual Meeting

Share Article

Fully integrated barcode scan capability on Pocket PCs.

TrialStat Corporation will be demonstrating their enhanced ClinicalAnalytics 3.0 (CA3) disconnected electronic data capture (EDC) technology now featuring barcode scanning capabilities at the 42nd Annual Drug Information Association (DIA) Annual Meeting in Philadelphia, PA.

Handheld devices with integrated bar code scanners may now be used with CA3 to allow researchers to capture barcode information directly into electronic forms on disconnected and wireless handheld devices. This enhancement requires no additional programming or configuration and can enable faster and more accurate data capture. Data captured using a scanner can also leverage the standard real time data validation capabilities of CA3.

”With this enhancement to Clinical Analytics 3.0, we continue to broaden the options available for electronic data capture,” said Jonathan Barker, president, TrialStat. “We strive to provide researchers and clinicians with data capture options that work with their best practices and methods.”

Barcodes are frequently used to identify items such as case report forms, subjects via wrist bands, and lab and pharmacy materials. CA3 users may now leverage existing bar coding practices to capture barcode label information directly into their electronic forms.

CA3 is the most advanced integrated EDC platform available to the clinical research market and has achieved a number of industry firsts including complete study configurability through a browser interface and seamless integration of handheld and disconnected devices. Both features empower the research team while reducing the time and expense associated with deploying EDC on studies. CA3 is offered as a web-based service thus providing access to a fully compliant, industrial grade platform without having to invest substantially in IT. TrialStat’s ClinicalAnalytics 3.0 with integrated support for disconnected devices is now generally available and is already in use in clinical studies in North America and Europe.

About TrialStat

TrialStat is a privately-held information technology firm with products and services that go beyond traditional EDC solutions to address the complete data management picture. From the industry’s most advanced integrated EDC platform to biostatistical support, adverse event coding, study monitoring and project management, TrialStat delivers flexible, proven data management on demand. For more information, please visit

For media and analyst inquiries only, contact:

Shelley Mullins

Media Relations, TrialStat            


Kathryn Schwab

Media Relations, TrialStat                


# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Shelley Mullins
Visit website